Quantitative assessment of cardiorespiratory fitness, skeletal muscle function, and body composition in adults with primary malignant glioma
Open Access
- 22 December 2009
- Vol. 116 (3) , 695-704
- https://doi.org/10.1002/cncr.24808
Abstract
BACKGROUND: The study was undertaken to evaluate cardiorespiratory fitness, skeletal muscle function, and body composition of patients with newly diagnosed and untreated, postsurgical primary malignant glioma. METHODS: By using a cross‐sectional design, patients with clinically stable (10 ± 7 days postsurgery) high‐grade glioma (HGG; n = 25) or low‐grade glioma (LGG; n = 10) were studied. Participants performed a cardiopulmonary exercise test (CPET) with expired gas analysis to assess cardiorespiratory fitness (peak oxygen consumption, VO2peak). Other physiological outcomes included skeletal muscle cross‐sectional area (CSA; magnetic resonance imaging), isokinetic muscle strength (isokinetic dynamometer), and body composition (air displacement plethysmography). Quality of life was assessed with the Functional Assessment of Cancer Therapy‐Brain scale. RESULTS: CPET was a feasible and safe procedure to assess VO2peak, with no serious adverse events. VO2peak indexed to total body weight and lean body mass (LBM) for both groups was 13.0 mL · weight · min−1 and 19 mL · LBM · min−1, the equivalent to 59% and 38% below age‐ and sex‐predicted normative values, respectively. Skeletal muscle strength and mid‐thigh CSA were lower in HGG relative to LGG patients (83 vs 125 Nm, P = .025; 94 vs 119 cm2, P = .171, respectively). Skeletal muscle isokinetic strength, CSA, and body composition outcomes predicted VO2peak (r = −0.59 to 0.68, P < .05). CONCLUSIONS: Postsurgical glioma patients have markedly reduced cardiorespiratory fitness, isokinetic strength, and CSA. Prospective studies are now required to determine whether such abnormalities influence treatment toxicity and clinical outcome as well as to test the effect of appropriately selected interventions to prevent and/or mitigate dysfunction. Cancer 2010. © 2009 American Cancer Society.Keywords
This publication has 49 references indexed in Scilit:
- Exercise intolerance in cancer and the role of exercise therapy to reverse dysfunctionThe Lancet Oncology, 2009
- Quality of life in adults with brain tumors: Current knowledge and future directionsNeuro-Oncology, 2009
- Cardiorespiratory exercise testing in clinical oncology research: systematic review and practice recommendationsThe Lancet Oncology, 2008
- Glioblastoma multiforme: an emerging paradigm of anti-VEGF therapyExpert Opinion on Biological Therapy, 2008
- Cardiovascular Risk Profile of Patients with HER2/neu-Positive Breast Cancer Treated with Anthracycline-Taxane–Containing Adjuvant Chemotherapy and/or TrastuzumabCancer Epidemiology, Biomarkers & Prevention, 2007
- Safety and feasibility of cardiopulmonary exercise testing in patients with advanced cancerLung Cancer, 2007
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement systemJournal of Pain and Symptom Management, 1997
- Impact of physical training on the ultrastructure of midthigh muscle in normal subjects and in patients treated with glucocorticoids.Journal of Clinical Investigation, 1987
- Thigh muscle mass and function in patients treated with glucocorticoidsEuropean Journal of Clinical Investigation, 1985